Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on the safety and effectiveness of galantamine in patients with Alzheimer disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Galantamine (galantamine)

Snippet

Sponsor: Janssen-Cilag S.p.A. | Conditions: Alzheimer Disease, Dementia | Phase 3 | Status: COMPLETED